Document:

Amended and Restated Investors Rights Agreement

 Exhibit 4.1 
  
 ALPHA AND OMEGA SEMICONDUCTOR LIMITED 
  
  
 AMENDED AND RESTATED 
 INVESTORS RIGHTS AGREEMENT

  
  
 December 29, 2006 
  
  

 TABLE OF CONTENTS 
  

					
	 	  	 	  	Page
	SECTION 1	  	 CERTAIN DEFINITIONS
	  	1
			
	SECTION 2	  	 RESTRICTIONS ON TRANSFERABILITY OF SECURITIES; REGISTRATION;
COMPLIANCE WITH SECURITIES ACT
	  	3
			
	2.1  	  	 Restrictions on Transferability
	  	3
			
	2.2  	  	 Restrictive Legend
	  	3
			
	2.3  	  	 Notice of Proposed Transfers
	  	3
			
	2.4  	  	 Requested Registration
	  	4
			
	2.5  	  	 Company Registration
	  	5
			
	2.6  	  	 S-3/F-3 Registrations
	  	6
			
	2.7  	  	 Expenses of Registration
	  	6
			
	2.8  	  	 Registration Procedures
	  	7
			
	2.9  	  	 Indemnification
	  	8
			
	2.10	  	 Information by Holder
	  	9
			
	2.11	  	 Rule 144 Reporting
	  	10
			
	2.12	  	 Assignment of Registration Rights
	  	10
			
	2.13	  	 Termination of Registration Rights
	  	10
			
	2.14	  	 “Market Stand-Off” Agreement
	  	11
			
	2.15	  	 Limitations on Subsequent Registration Rights
	  	11
			
	2.16	  	 Jurisdiction
	  	11
			
	SECTION 3	  	 NEW ISSUANCE RIGHT OF FIRST REFUSAL
	  	11
			
	3.1  	  	 Preemptive Right
	  	11
			
	3.2  	  	 Notification
	  	12
			
	3.3  	  	 Waiver
	  	12
			
	3.4  	  	 Issuance
	  	12
			
	3.5  	  	 Excluded Securities
	  	12
			
	3.6  	  	 Termination
	  	12
			
	3.7  	  	 Assignment
	  	13
			
	SECTION 4	  	 FINANCIAL INFORMATION
	  	13
			
	4.1  	  	 Financial Information
	  	13
			
	4.2  	  	 Additional Rights for the Major Series B Investors and Major Series C Investors
	  	13
			
	4.3  	  	 Additional Rights for the Major Series C Investors
	  	13
			
	4.4  	  	 Inspection
	  	14
			
	4.5  	  	 Assignment
	  	14
			
	4.6  	  	 Termination
	  	14

  

 i 

					
	 	  	 	  	Page
	SECTION 5	  	 ADDITIONAL COVENANTS
	  	14
			
	5.1  	  	 Series C Director
	  	14
			
	5.2  	  	 Meetings of the Board of Directors
	  	15
			
	5.3  	  	 Successor Indemnification
	  	15
			
	5.4  	  	 Board Expenses
	  	15
			
	5.5  	  	 Insurance
	  	15
			
	5.6  	  	 Termination
	  	15
			
	SECTION 6	  	 MISCELLANEOUS
	  	15
			
	6.1  	  	 Governing Law
	  	15
			
	6.2  	  	 Additional Series C Investors
	  	15
			
	6.3  	  	 Successors and Assigns
	  	15
			
	6.4  	  	 Entire Agreement; Amendment
	  	15
			
	6.5  	  	 Notices, Etc
	  	16
			
	6.6  	  	 Delay or Omissions
	  	16
			
	6.7  	  	 Expenses
	  	16
			
	6.8  	  	 Counterparts
	  	16
			
	6.9  	  	 Severability
	  	16
			
	6.10	  	 Conflict
	  	16
			
	6.11	  	 Aggregation of Shares
	  	16

  

 ii 

 ALPHA AND OMEGA SEMICONDUCTOR LIMITED 
 AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT 
 This Amended and Restated Investors Rights Agreement is made as of December 29, 2006 (the “Agreement”), by and among Alpha and Omega Semiconductor Limited, an exempted company
incorporated with limited liability and existing under the laws of Bermuda (the “Company”), the holders of Series A Preferred Shares of the Company (the “Series A Investors”; listed on
Exhibit A to this Agreement), the holders of Series B Preferred Shares of the Company (the “Series B Investors”; listed on Exhibit B to this Agreement), the holders of Series C Preferred Shares
of the Company (the “Series C Investors”; listed on Exhibit C to this Agreement) and the additional Series C Investors (the “Additional Series C Investors”) who may become parties to this
Agreement in accordance with Section 6.2 hereof. Each of the Series A Investors, Series B Investors, Series C Investors and Additional Series C Investors is referred to hereinafter as an “Investor,” and the
Series A Investors, Series B Investors, Series C Investors and Additional Series C Investors are collectively referred to hereinafter as the “Investors.” 
 RECITALS 
 WHEREAS: certain of the
Investors (the “Prior Investors”) (i) hold Series A Preferred Shares of the Company (the “Series A Preferred”) and/or Series B Preferred Shares of the Company (the “Series B Preferred”) and/or
shares of Common Shares issued upon conversion thereof, (ii) are parties to that certain Amended and Restated Investors Rights Agreement dated as of March 30, 2006 by and among the Company, such Prior Investors and other holders of the
Series A Preferred or Series B Preferred (the “Prior Agreement”), and (iii) are the holders of at least a majority of the Common Shares issued or issuable upon conversion of the Series A Preferred and Series B Preferred subject
to or enjoying the rights under the Prior Agreement. 
 WHEREAS: certain of the Investors and the Company are parties to
that certain Series C Preferred Shares Purchase Agreement dated as of the date hereof (the “Series C Purchase Agreement”) relating to the issue and sale of Series C Preferred Shares of the Company (the “Series C
Preferred,” and, together with the Series A Preferred and Series B Preferred, the “Preferred Shares”). 
 WHEREAS: the obligations of the Company and certain of the Investors under the Series C Purchase Agreement are conditioned, among other things, upon the execution and delivery of this Agreement by the Investors, the Prior
Investors and the Company, and the Prior Investors and the Company desire to amend and restate the Prior Agreement as provided herein. 
 NOW, THEREFORE: In consideration of the mutual promises and covenants set forth herein, and other consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Prior Investors hereby agree to amend and
restate the Prior Rights Agreement as set forth herein, and the parties hereto agree as follows: 
 AGREEMENT

 SECTION 1 
 CERTAIN DEFINITIONS 
 As used in this Agreement, the following terms
shall have the following respective meanings: 
 1.1 “1934 Act” shall mean the Securities Exchange Act of 1934,
as amended, or any similar successor federal statute and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time. 
  

 1 

 1.2 “affiliate” shall mean, with respect to any specified Person, any other
Person who or which, directly or indirectly, controls, is controlled by, or is under common control with such specified Person, including without limitation any general partner, officer, director, or manager of such Person and any venture capital
fund now or hereafter existing that is controlled by one or more general partners or managing members of, or shares the same management company with, such Person. 
 1.3 “Commission” shall mean the Securities and Exchange Commission or any other federal agency at the time administering the Securities Act. 
 1.4 “Common Shares” shall mean the Common Shares of the Company. 
 1.5 “Conversion Shares” shall mean the Common Shares issued or issuable upon conversion of the Preferred Shares.

 1.6 “Holder” or “Holders” shall mean any person or persons owning Registrable Securities or
any assignee thereof in accordance with Section 2 hereof. 
 1.7 “Initial Closing” shall have the meaning
set forth in Section 2.4(a) hereof. 
 1.8 “Initiating Holders” shall mean any Investors or permitted
transferees of such Investors under Section 2.12 hereof, who in the aggregate are Holders of not less than thirty percent (30%) of the outstanding Registrable Securities. 
 1.9 “Person” shall mean any individual, corporation, partnership, trust, limited liability company, association or other
entity. 
 1.10 “Qualified IPO” shall mean the firm commitment underwritten public offering pursuant to an
effective registration statement under the Securities Act covering the offer and sale of Common Shares for the account of the Company, provided that (i) the aggregate gross proceeds to the Company are $50,000,000 or more and (ii) the
public offering price per share (including underwriting discounts and commissions) is not less than $7.50 (as adjusted to reflect any subsequent share dividends, share splits, reverse share splits or recapitalizations). 
 1.11 “register”, “registered” and “registration” refer to a registration effected by
preparing and filing a registration statement in compliance with the Securities Act, and the declaration or ordering of the effectiveness of such registration statement. 
 1.12 “Registrable Securities” shall mean (i) Conversion Shares, and (ii) any Common Shares issued in respect of, in exchange for or in replacement of the Conversion Shares or
other securities issued pursuant to the conversion of the Preferred Shares upon any share split, share combination, share dividend, recapitalisation, consolidation or a similar event. Securities that have previously been sold to the public pursuant
to a registered public offering or Rule 144 of the Securities Act, or that have been sold in a private transaction in which the transferor’s registration rights under this Agreement are not validly assigned in accordance with this
Agreement, shall cease to be Registrable Securities. 
 1.13 “Registration Expenses” shall mean all expenses
incurred in complying with registrations, filings or qualifications under Sections 2.4, 2.5 and 2.6 hereof, including, without limitation, all registration, qualification and filing fees, accounting fees, printing expenses, escrow fees, fees and
disbursements of counsel for the Company, all fees and disbursements of one special counsel for the selling Holders, blue-sky fees and expenses, and the expense of any special audits incident to or required by any such registration (but excluding
the compensation of regular employees of the Company). 
 1.14 “Restricted Securities” shall mean the
securities of the Company required to bear the legend set forth in Section 2.2 hereof (or any similar legend). 
  

 2 

 1.15 “Securities” shall mean (i) the Company’s equity or debt
securities, (ii) rights, options or warrants to subscribe for, purchase or otherwise acquire any equity or debt security of the Company and (iii) any agreement or commitment to issue any of the foregoing. 
 1.16 “Securities Act” shall mean the Securities Act of 1933, as amended, or any similar successor federal statute and the
rules and regulations of the Commission thereunder, all as the same shall be in effect at the time. 
 1.17 “Selling
Expenses” shall mean all underwriting discounts, selling commissions and share transfer taxes applicable to the sale of Registrable Securities pursuant to registration, and fees and disbursements of counsel for any Holder (other than the
fees and disbursements of one special counsel to the Holders included in Registration Expenses). 
 SECTION 2 

RESTRICTIONS ON TRANSFERABILITY OF SECURITIES; REGISTRATION; 
 COMPLIANCE WITH SECURITIES ACT 
 2.1
Restrictions on Transferability. The Common Shares and the Conversion Shares shall not be transferable except upon the conditions specified in this Section 2, which conditions are intended to ensure compliance with the provisions of the
Securities Act, or, in the case of Section 2.14 hereof, to assist in an orderly distribution. Each Investor will cause any proposed transferee of the Common Shares and the Conversion Shares held by such Investor to agree to take and hold such
securities subject to the provisions and upon the conditions specified in this Section 2 (including the “market stand-off” provisions of Section 2.14). 
 2.2 Restrictive Legend. Each certificate representing (a) the Common Shares, (b) the Conversion Shares and (c) any
other securities issued in respect of the Common Shares or Conversion Shares or Common Shares issuable upon any share split, share combination, share dividend, recapitalisation, consolidation or similar event, shall (unless otherwise permitted by
the provisions of Section 2.3 below) be stamped or otherwise imprinted with a legend in substantially the following form (in addition to any legend required under applicable state securities laws): 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER SAID ACT. 
 2.3 Notice of Proposed Transfers. The holder of each certificate representing Restricted Securities agrees to comply in all respects with the provisions of this Section 2.3. Prior to any
proposed transfer of any Restricted Securities (unless there is in effect a registration statement under the Securities Act covering the proposed transfer), the holder thereof shall give written notice to the Company of such holder’s intention
to effect such transfer. Each such notice shall describe the manner and circumstances of the proposed transfer in sufficient detail, and (except in transactions in compliance with Rule 144) shall be accompanied by either (i) a written opinion
of legal counsel who shall be reasonably satisfactory to the Company, addressed to the Company and reasonably satisfactory in form and substance to the Company’s counsel, to the effect that the proposed transfer of the Restricted Securities may
be effected without registration under the Securities Act, or (ii) a “no action” letter from the Commission to the effect that the transfer of such securities without registration will not result in a recommendation by the staff of
the Commission that action be taken with respect thereto, whereupon the holder of such Restricted Securities shall be entitled to transfer such Restricted Securities in accordance with the terms of the notice delivered by the holder to the Company.
Each certificate evidencing the Restricted Securities transferred pursuant to the above shall bear the legend set forth in Section 2.2 above, except that such certificate shall not bear such restrictive legend if, in the opinion of counsel for
the Company, such legend is not required in order to establish compliance with any provisions of the Securities Act. 
  

 3 

 2.4 Requested Registration. 
 (a) Subject to the terms of this Agreement, in the event that the Company shall receive from the Initiating Holders at any
time after the earlier of (i) two (2) years following the initial closing of the purchase and sale of the Series C Preferred pursuant to the Series C Purchase Agreement (the “Initial Closing”) and (ii) six
(6) months following a Qualified IPO, a written request that the Company effect a registration with respect to all or a part of the Registrable Securities, the Company shall (i) promptly give written notice of the proposed registration to
all other Holders and (ii) as soon as practicable, use its reasonable efforts to effect registration of the Registrable Securities specified in such request, together with any Registrable Securities of any Holder joining in such request as are
specified in a written request given within twenty (20) days after written notice from the Company. 
 (b)
The Company is obligated to effect only two (2) such registrations pursuant to this Section 2.4. 
 (c)
Notwithstanding the foregoing, the Company shall not be obligated to take action to effect such registration pursuant to this Section 2.4: 
 (i) In any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting such registration, qualification or compliance unless the Company
is already subject to service in such jurisdiction and except as may be required by the Securities Act; 
 (ii)
If the Registrable Securities proposed to be sold by the Initiating Holders have aggregate proceeds (after deduction for underwriters’ discounts and expenses related to the issuance) of less than $4,000,000; or 
 (iii) If the Company shall furnish to the Initiating Holders a certificate signed by the President or Chief Executive Officer
of the Company stating that the Board of Directors of the Company (the “Board of Directors”) has determined in its good faith judgment, that it would be seriously detrimental to the Company and its shareholders for such registration
statement to be filed at such time, the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request of the Initiating Holders (provided that such right shall not be used more
than once in any twelve (12) month period); provided further that the Company shall not register any securities for account of itself or any other shareholder during such ninety (90) day period. 
 (d) Underwriting. If the Initiating Holders intend to distribute the Registrable Securities covered by their request
by means of an underwriting, they shall so advise the Company as part of their request made pursuant to this Section 2.4 and the Company shall include such information in the written notice referred to in Section 2.4(a)(i). The right of
any Holder to registration pursuant to this Section 2.4 shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided
herein. 
 The Company shall (together with all Holders and other parties proposing to distribute their securities through such
underwriting) enter into an underwriting agreement in customary form with the representative(s) of the underwriter(s) selected for such underwriting by the Initiating Holders. Notwithstanding any other provision of this Section 2.4, if the
underwriter (or the Company after consultation with the Initial Holders if the offering is not underwritten) advises the Initiating Holders in writing that it has determined in good faith that the marketing factors require a limitation of the number
of shares to be underwritten, the Company and the underwriter shall so advise the Initiating Holders and all Holders of Registrable Securities, and the underwriter may limit the number of Registrable Securities to be included in the registration and
underwriting on a pro rata basis based upon the total number of securities (including, without limitation, Registrable Securities) entitled to registration held by the Holders exercising their respective registration rights under
Section 2.4(a); provided, however, that the number of shares of Registrable Securities to be included in such underwriting shall not be reduced unless all other securities proposed to be sold by the Company or persons other than the
Holders exercising their respective registration rights under Section 2.4(a) are first entirely excluded from the underwriting. The number of

  

 4 

 
securities includable by any Holder or other person may, in the discretion of the underwriters, be rounded to the nearest one hundred (100) shares. No securities excluded from the
underwriting by reason of the underwriter’s marketing limitation shall be included in such registration. 
 If any Holder
of Registrable Securities disapproves of the terms of the underwriting, such person may elect to withdraw therefrom by written notice to the Company, the underwriter and the Initiating Holders. The Registrable Securities and/or other securities so
withdrawn shall also be withdrawn from registration; provided, however, that, if by the withdrawal of such Registrable Securities a greater number of Registrable Securities held by other participating Holders may be included in such
registration (up to the maximum of any limitation imposed by the underwriter), then the Company shall allocate such greater number of Registrable Securities to such Holders in proportion, as nearly as practicable, to the respective amount of
Registrable Securities held by such participating Holders. 
 If the underwriter has not limited the number of Registrable
Securities to be underwritten, the Company may include securities for its own account or for the account of other shareholders of the Company in such registration if the underwriter so agrees. 
 2.5 Company Registration. 
 (a) Registration. If at any time or from time to time the Company shall determine to register any of its securities, either for its own account or the account of a security holder or holders
exercising their respective demand registration rights, other than (i) a registration on Form S-8 (or a similar or successor form) relating solely to employee option, share purchase or other benefit plans, or (ii) a registration on Form
S-4 (or similar or successor form) relating solely to a Securities and Exchange Commission Rule 145 transaction, the Company will: 
 (i) Promptly give to each Holder written notice thereof; and 
 (ii)
Include in such registration (and any related qualification under blue sky laws or other compliance), and in any underwriting involved therein, all Registrable Securities specified in a written request or requests, made within twenty (20) days
after mailing of written notice by the Company, by any Holder or Holders, except as set forth in Section 2.5(b) below. 
 (b) Underwriting. If the registration of which the Company gives notice is for a registered public offering involving an underwriting, the Company shall so advise the Holders as a part of the
written notice given pursuant to Section 2.5(a)(i). In such event, the right of any Holder to registration pursuant to Section 2.5 shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such
Holder’s Registrable Securities in the underwriting to the extent provided herein. 
 All Holders proposing to distribute
their securities through such underwriting shall (together with the Company and other holders of securities distributing their securities through such underwriting) enter into an underwriting agreement in customary form with the underwriter or
underwriters selected for such underwriting by the Company. Notwithstanding any other provision of this Section 2.5, if the managing underwriter determines that marketing factors require a limitation of the number of shares to be underwritten,
the underwriter may limit the number of Registrable Securities to be included in the registration and underwriting, on a pro rata basis based on the total number of securities (including, without limitation, Registrable Securities) entitled to
registration pursuant to registration rights granted to the participating Holders by the Company; provided, however, that the number of shares of Registrable Securities to be included in such underwriting shall not be reduced unless all other
securities proposed to be sold by the employees or directors of the Company other than the Holders exercising their respective registration rights under Section 2.5(a) are first entirely excluded from the underwriting; provided further
that except for the Qualified IPO, at least 25% of the Registrable Securities requested to be included in such underwriting shall be so included, unless such offering is the Qualified IPO, in which case the selling Holders may be totally excluded if
the underwriters make the determination described above. The number of securities includable by any Holder or other person may, in the discretion of the

  

 5 

 
underwriters, be rounded to the nearest one hundred (100) shares. No securities excluded from the underwriting by reason of the underwriter’s marketing limitation shall be included in
such registration. 
 If any Holder disapproves of the terms of any such underwriting, he or she may elect to withdraw therefrom
by written notice to the Company and the underwriter. Any securities excluded or withdrawn from such underwriting shall be withdrawn from such registration. 
 If the underwriter has not limited the number of shares to be underwritten for the Company’s account and the accounts of the Holders, the Company may include securities for the accounts of employees,
officers, directors and consultants. 
 2.6 S-3/F-3 Registrations. If the Company is requested (after the Company
qualifies for registration on Form S-3 or F-3 or any comparable or successor form or forms) to undertake a Form S-3 or F-3 or equivalent short-form registration, regardless of its designation and any related qualification or compliance, of its
securities by the Holders of Registrable Securities for an offering estimated to result in aggregate offering proceeds of at least $1,000,000, net of allowances, discounts, and underwriting expenses, the Company shall promptly give notice of such
proposed registration to all Holders of Registrable Securities and the Company shall, as expeditiously as possible, use its reasonable efforts to effect the registration on Form F-3 of the Registrable Securities which the Company has been requested
to register (i) in each request and (ii) in any response given within twenty (20) days to a notice from the Company pursuant to this Section 2.6. Notwithstanding the foregoing, however, such registration shall be subject to the
following: 
 (a) The Company shall not be required to effect more than one (1) such registration pursuant
to this Section 2.6 in any twelve (12) month period. 
 (b) The Company shall not be required to effect
a registration pursuant to this Section 2.6 within one hundred eighty (180) days of the effective date of any registration referred to in Section 2.4. 
 The Company may include in the registration under this Section 2.6 any other Common Shares (including issued and outstanding Common Shares as to which the holders thereof have contracted with the
Company for “piggyback” registration rights), so long as the inclusion in such registration of such shares will not, in the opinion of the managing underwriter (or in the reasonable opinion of the Company in the event that the offering is
not underwritten), interfere with the successful marketing in accordance with the intended method of sale or other disposition of all the shares of Registrable Securities sought to be registered by the Holder or Holders of Registrable Securities
pursuant to this Section 2.6. If it is determined as provided above that there will be such interference, the other Common Shares sought to be included by the Company shall be excluded to the extent deemed necessary by the managing underwriter
(or the Company if the offering is not underwritten), and all other Common Shares held by other parties shall be excluded before the exclusion of any shares of Registrable Securities held by the Holders who desire to have their shares included in
the registration and offering. If, as contemplated above, and after excluding all other Common Shares held by other parties, the Common Shares of the Holders are to be excluded, the number of Common Shares of each participating Holder which are to
be excluded shall be proportionate to the number of shares which such party is seeking to register. 
 2.7 Expenses of
Registration. All Registration Expenses (other than Selling Expenses) incurred in connection with any registration pursuant to Section 2.4 or 2.5 and up to two (2) registrations pursuant to Section 2.6 shall be borne by the
Company. Unless otherwise stated, all Selling Expenses relating to securities registered by the Holders shall be borne by the Holders of such securities pro rata on the basis of the number of shares so registered. 
  

 6 

 2.8 Registration Procedures. In the case of each registration, qualification or
compliance effected by the Company pursuant to this Section 2, the Company will keep each Holder advised in writing as to the initiation of each registration, qualification and compliance and as to the completion thereof. At its expense the
Company will: 
 (a) prepare and file with the Commission a registration statement with respect to such
Registrable Securities and use its reasonable best efforts to cause such registration statement to become effective and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration
statement effective for a period of up to one hundred twenty (120) days or, if earlier, until the distribution contemplated in the registration statement has been completed; provided, however, that (i) such one hundred twenty
(120) day period shall be extended for a period of time equal to the period the Holder refrains, at the request of an underwriter of Common Shares (or other securities) of the Company, from selling any securities included in such registration,
and (ii) in the case of any registration of Registrable Securities on Form S-3 or F-3 that are intended to be offered on a continuous or delayed basis, subject to compliance with applicable Commission rules, such one hundred twenty
(120) day period shall be extended for up to 120 days, if necessary, to keep the registration statement effective until the distribution contemplated in the registration statement has been completed; 
 (b) prepare and file with the Commission such amendments and supplements to such registration statement, and the prospectus
used in connection with such registration statement, as may be necessary to comply with the Securities Act in order to enable the distribution contemplated in the registration statement to be completed; 
 (c) furnish to the selling Holders such numbers of copies of a prospectus, including a preliminary prospectus, as required by
the Securities Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities; 
 (d) register and qualify the securities covered by such registration statement under such other securities or blue-sky laws
of such jurisdictions as shall be reasonably requested by the selling Holders; provided that the Company shall not be required to qualify to do business or to file a general consent to service of process in any such states or jurisdictions, unless
the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 
 (e) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the underwriter(s) of such offering; 
 (f) cause all such Registrable Securities covered by such registration statement to be listed on a national securities
exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued by the Company are then listed; 
 (g) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and provide a CUSIP number for all such Registrable Securities, in each case not later than
the effective date of such registration; 
 (h) promptly make available for inspection by the selling Holders,
any managing underwriter(s) participating in any disposition pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling Holders, all financial and other records,
pertinent corporate documents, and properties of the Company, and cause the Company’s officers, directors, employees, and independent accountants to supply all information that are reasonably requested by any such seller, underwriter, attorney,
accountant, or agent, in each case, as necessary or advisable to verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith; 
 (i) notify each selling Holder, promptly after the Company receives notice thereof, of the time when such registration
statement has been declared effective or a supplement to any prospectus forming a part of such registration statement has been filed; and 
 (j) after such registration statement becomes effective, notify each selling Holder of any request by the Commission that the Company amend or supplement such registration statement or prospectus.

  

 7 

 2.9 Indemnification. 
 (a) The Company will, and does hereby undertake to, indemnify and hold harmless each Holder and each person, if any,
controlling such Holder within the meaning of Section 15 of the Securities Act, with respect to which registration, qualification or compliance has been effected pursuant to this Section 2, and each underwriter, if any, and each person who
controls any underwriter within the meaning of Section 15 of the Securities Act, against all expenses, claims, losses, damages and liabilities (or actions in respect thereof), including settlement of any litigation, commenced or threatened, to
which they may become subject under the Securities Act, the 1934 Act, or other federal or state law, arising out of or based on compliance with any untrue statement (or alleged untrue statement) of a material fact contained in any registration
statement, prospectus (preliminary or final), offering circular or other document or amendments thereto, or arising out of or based on any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances in which they were made, not misleading, or arising out of or based on any violation by the Company of any federal, state or common law rule or regulation applicable to the Company and
relating to action or inaction required of the Company in connection with any such registration, qualification or compliance, and will reimburse each such Holder and each person, if any, controlling such Holder, and each such underwriter and each
person who controls any such underwriter, for any legal and any other expenses reasonably incurred in connection with investigating, preparing or defending any such claim, loss, damage, liability or action, provided that the Company will not be
liable in any such case to the extent that any such claim, loss, damage, liability or expense arises out of or is based on any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written
information furnished to the Company by an instrument executed by such Holder or underwriter expressly for use in connection with such registration, and provided further that, the indemnity agreement contained in this Section 2.9(a) shall not
apply to amounts paid in settlement of any such loss, claim, damage, liability, or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld). 
 (b) Each Holder will, if Registrable Securities held by such Holder are included in the securities as to which such
registration, qualification or compliance is being effected, severally and not jointly, indemnify and hold harmless the Company, each underwriter, if any, of the Company’s securities covered by such a registration statement, each person who
controls the Company or such underwriter within the meaning of Section 15 of the Securities Act, and each other such Holder and each person, if any, controlling such Holder within the meaning of Section 15 of the Securities Act, against
all claims, losses, damages and liabilities (or actions in respect thereof to which they may become subject) arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any such registration
statement, prospectus, offering circular or other document, or amendments thereto, or any omission (or alleged omission) to state therein a material fact required-to be stated therein in light of the circumstances in which they were made, or
necessary to make the statements therein, not misleading, and will reimburse the Company, such Holders, underwriters or control persons for any legal or any other expenses reasonably incurred in connection with investigating or defending any such
claim, loss, damage, liability or action, in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such registration statement, prospectus, offering
circular or other document in reliance upon and in conformity with written information furnished to the Company by an instrument executed by such Holder expressly for use in connection with such registration; provided that the indemnity agreement
contained in this Section 2.9(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, or action if such settlement is effected without the consent of the Holder (which consent shall not be unreasonably
withheld); provided further that the obligations of such Holder hereunder shall be limited to an amount equal to the net proceeds to each such Holder of Registrable Securities from the sale of such Registrable Securities as contemplated herein.

 (c) Each party entitled to indemnification under this Section 2.9 (the “Indemnified
Party”) shall give notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may be sought, and shall

  

 8 

 
deliver written notice to the Indemnifying Party of commencement thereof. The Indemnifying Party, at its sole option, may participate in or assume the defence of any such claim or any litigation
resulting therefrom with counsel reasonably satisfactory to the Indemnified Party, and the Indemnified Party may participate in such defence at the Indemnified Party’s expense. The failure of any Indemnified Party to give notice as provided
herein shall not relieve the Indemnifying Party of its obligations under this Section 2 except to the extent that such failure to give notice shall materially adversely affect the Indemnifying Party in the defence of any such litigation. No
Indemnifying Party, in the defence of any such claim or litigation, shall, except with the consent of each Indemnified Party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term a release
from all liability in respect to such claim or litigation by the claimant or plaintiff to such Indemnified Party. 
 (d) To provide for just and equitable contribution to joint liability under the Securities Act in any case in which either (i) any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this
Section 2.9 but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be
enforced in such case, notwithstanding the fact that this Section 2.9 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any party hereto for which indemnification is
provided under this Section 2.9, then, and in each such case, such parties will contribute to the aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from others) in such proportion as is
appropriate to reflect the relative fault of each of the Indemnifying Party and the Indemnified Party in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage, liability, or expense, as well as to
reflect any other relevant equitable considerations. The relative fault of the Indemnifying Party and of the Indemnified Party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material
fact, or the omission or alleged omission of a material fact, relates to information supplied by the Indemnifying Party or by the Indemnified Party and the parties’ relative intent, knowledge, access to information, and opportunity to correct
or prevent such statement or omission; provided, however, that, in any such case, (x) no Holder will be required to contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold
by such Holder pursuant to such registration statement, and (y) no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation; and provided further that in no event shall a Holder’s liability pursuant to this Section 2.9(d), when combined with the amounts paid or payable by such Holder pursuant to Section 2.9(b),
exceed the net proceeds from the offering received by such Holder. 
 (e) Notwithstanding the foregoing, to the
extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting
agreement shall control. 
 (f) Unless otherwise superseded by an underwriting agreement entered into in
connection with the underwritten public offering, the obligations of the Company and Holders under this Section 2.9 shall survive the completion of any offering of Registrable Securities in a registration under this Section 2, and
otherwise shall survive the termination of this Agreement. 
 2.10 Information by Holder. Each Holder of Registrable
Securities included in any registration shall furnish to the Company such information regarding such Holder and the distribution proposed by such Holder as the Company may reasonably request in writing and as shall be required in connection with any
registration, qualification or compliance referred to in this Section 2. 
  

 9 

 2.11 Rule 144 Reporting. With a view to making available the benefits of certain
rules and regulations of the Commission which may at any time permit the sale of the Restricted Securities to the public without registration, the Company agrees to: 
 (a) Register its Common Shares under Section 12(g) of the 1934 Act, as amended, as soon as practicable, but in any
event not later than ninety (90) days after the close of the Company’s first fiscal year following the effective date of the first registration statement filed by the Company, relating to a public offering other than to employees of the
Company under an employee option plan or employee share purchase plan; 
 (b) Make and keep public information
available, as those terms are understood and defined in Rule 144 under the Securities Act, at all times after the effective date of the first registration under the Securities Act filed by the Company for an offering of its securities to the
general public; 
 (c) File with the Commission in a timely manner all reports and other documents required of
the Company under the Securities Act and the 1934 Act (at any time after it has become subject to such reporting requirements); and 
 (d) Furnish to the Holder, so long as Holder owns any Restricted Securities, written notice of the Company’s qualification as a registrant, as soon as practicable after such qualification; the
Company further shall furnish forthwith upon request a written statement as to its compliance with the reporting requirements of said Rule 144 (at any time after ninety (90) days after the effective date of the first registration statement
filed by the Company for an offering of its securities to the general public), and of its compliance with the Securities Act and the Securities Exchange Act (at any time after it has become subject to such reporting requirements); the Company shall
provide forthwith upon written request a copy of the most recent annual or quarterly report of the Company, and such other reports and documents of the Company as a Holder may reasonably request in availing itself of any rule or regulation of the
Commission allowing a Holder to sell any such securities without registration. 
 2.12 Assignment of Registration Rights.
The rights to cause the Company to register securities and related rights granted to each Investor under Section 2 may not be assigned except: 
 (a) To a purchaser acquiring (i) not less than 500,000 shares of Registrable Securities from a Series A Investor, (ii) not less than 250,000 shares of Registrable Securities from a
Series B Investor, or (iii) not less than 250,000 shares of Registrable Securities from a Series C Investor; 
 (b) To a successor entity to an Investor pursuant to a reorganisation or recapitalisation of an Investor; 
 (c) To the partners or retired partners or members or retired members of an Investor; or 
 (d) Pursuant to an inter vivos transfer to Investor’s ancestors, descendants or spouse or to a trustee for their benefit; 
 provided, however, that in each case the Company receives notice within twenty (20) days following such assignment. For the
purposes of determining the number of shares of Registrable Securities held by a transferee or assignee, the holdings of transferees and assignees of a partnership, limited liability company or corporation who are partners or retired partners of
such partnership (including spouses and ancestors, lineal descendants and siblings of such partners or spouses who acquire Registrable Securities by gift, will or intestate succession), members or former members or shareholders shall be aggregated
together and with the partnership. 
 2.13 Termination of Registration Rights. The registration rights and related rights
granted pursuant to Section 2 shall terminate as to each Holder (and permitted transferee under Section 2.12 above) upon the occurrence of any of the following: 
 (a) At such time as all Restricted Securities held by such Holder or permitted transferee can be sold within a three
(3) month period pursuant to Rule 144 of the Securities Act (or its successor provision); or 
 (b) Six
(6) years following the Initial Closing. 
  

 10 

 2.14 “Market Stand-Off” Agreement. Any Holder, if required by the Company
and an underwriter of Common Shares (or other securities) of the Company, shall agree not to sell or otherwise transfer or dispose of any Common Shares (or other securities) of the Company held by such Holder during the period not to exceed one
hundred eighty (180) days as requested by the managing underwriter following the effective date of the first registration statement of the Company filed under the Securities Act; provided that all officers and directors of the Company and
holders of one percent (1%) or more of the Company’s outstanding shares enter into, and remain bound by, similar agreements; provided further that the foregoing provisions of this Section 2.14 shall not apply to the sale of any Common
Shares to an underwriter pursuant to an underwriting agreement. Such agreement shall be in writing in the form satisfactory to the Company and such underwriter. The Company may impose a stop-transfer instruction with respect to the shares (or other
securities) subject to the foregoing restriction until the end of such period. Notwithstanding the foregoing, nothing in this Section 2.14 shall prevent a Holder from making a transfer of any Common Shares that was listed on a national stock
exchange, actively traded over-the-counter or traded on the Nasdaq National Market at the time it was acquired by the Holder, including any Common Shares acquired in the Company’s initial public offering. 
 2.15 Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without the
prior written consent of the Holders of a majority of the Registrable Securities then outstanding, enter into any agreement with any holder or prospective holder of any securities of the Company that would allow such holder or prospective holder
(i) to include such securities in any registration unless, under the terms of such agreement, such holder or prospective holder may include such securities in any such registration only to the extent that the inclusion of such securities will
not reduce the number of the Registrable Securities of the Holders that are included or (ii) to demand registration of any securities held by such holder or prospective holder; provided that this limitation shall not apply to any additional
Investor who becomes a party to this Agreement in accordance with Section 6.2. 
 2.16 Jurisdiction. The terms of
this Section 2 are drafted primarily in contemplation of securities offerings in the United States of America (the “United States”). The parties recognize, however, the possibility that there may be one or more registrations in
a jurisdiction other than the United States. It is, accordingly, their intention that whenever this Agreement refers to a law or institution of the United States, but the parties wish to effectuate a registration in a different jurisdiction,
reference in this Agreement to the laws or institutions of the United States shall be read as referring, mutatis mutandis, to the comparable laws or institutions of the jurisdiction in question. For avoidance of doubt, the Holders
shall be entitled to reasonably equivalent or analogous rights with respect to any other offering of the Company’s securities in such other jurisdiction in which the Company undertakes to publicly offer or list such securities for trading on a
recognized securities exchange. 
 SECTION 3 
 NEW ISSUANCE RIGHT OF FIRST REFUSAL 
 3.1 Preemptive Right.

 (a) If, at any time prior to the expiration of the period set forth in Section 3.6 below, the Company
should desire to issue any Securities, it shall give (i) a Series A Investor holding not less than 500,000 shares of Registrable Securities (each, a “Major Series A Investor” and collectively, the “Major Series A
Investors”), (ii) a Series B Investor holding not less than 250,000 shares of Registrable Securities (each, a “Major Series B Investor” and collectively, the “Major Series B Investors”), and
(iii) a Series C Investor holding not less than 250,000 shares of Registrable Securities (each, a “Major Series C Investor” and collectively, the “Major Series C Investors” and together with the Major
Series A Investors and the Major Series B Investors, the “Major Investors”) the first right to purchase such Major Investor’s Pro Rata Portion (as defined below) of all of such Securities on the same terms and at the same price
as the Company is willing to sell such Securities to any other person. Such Major Investor’s “Pro Rata Portion” of the Securities shall be equal to that percentage of the then outstanding Common Shares of the Company held by such
Major Investor on the date of the Company’s written notification referred to in Section 3.2 below. 
  

 11 

 (b) For purposes of this Section 3.1, the Common Shares of the Company
held by such Major Investor shall be adjusted for share dividends, share splits, share combinations, recapitalisations and the like, and shall be deemed to include Common Shares issued or issuable upon conversion of the Preferred Shares or any other
securities of the Company on an as-converted basis. In addition, a Major Investor shall be entitled to apportion the right of first offer hereby granted to it among itself and its affiliates in such proportions as it deems appropriate. 

3.2 Notification. Prior to any sale or issuance by the Company of any Securities, the Company shall notify each Major Investor, in
writing, of its intention to sell and issue such Securities, setting forth in reasonable detail the terms, price and description under which it proposes to make such sale. Within fifteen (15) days thereafter, each Major Investor shall notify
the Company of whether such Major Investor chooses to exercise such Major Investor’s option and elect to purchase such Major Investors’ Pro Rata Portions (or any part thereof) of the Securities so offered. If not all of the Major Investors
elect to purchase their entire Pro Rata Portion of the Securities, then the Company shall promptly notify in writing the Major Investors who do so elect and shall offer such Major Investors the right to acquire such unsubscribed shares. Each such
Major Investor shall have fifteen (15) days after receipt of such notice to notify the Company of its election to purchase all or a portion of the unsubscribed shares. 
 3.3 Waiver. If the Major Investors fail to exercise in full rights of the first refusal pursuant to Section 3.2, the Company
may, during a period of ninety (90) days following the end of such fifteen (15) day period, sell and issue such Securities as to which Major Investors do not indicate a desire to purchase to another person upon the same terms and
conditions as those set forth in the notice to Major Investors but at a price at least as great as the price offered to the Investors; provided, however, that failure by a Major Investor to exercise its option to purchase with respect to one
offering, sale and issuance of Securities shall not affect its option to purchase Securities in any subsequent offering, sale and purchase. In the event the Company has not sold the Securities, or entered into a binding agreement to sell the
Securities, within such ninety (90) day period, the Company shall not thereafter issue or sell any Securities without first offering such Securities to the Major Investors in the manner provided above. 
 3.4 Issuance. If an Investor gives the Company notice that such Investor desires to purchase any of the Securities offered by the
Company, payment for the Securities shall be by check or wire transfer, against delivery of the Securities at the executive offices of the Company within ten (10) days after giving the Company such notice, or if later, the closing date for the
sale of such Securities. The Company shall take all such action as may be required by any regulatory authority in connection with the exercise by the Investor of the right to purchase Securities as set forth in this Section 3, but the right of
an Investor is subject to the Company’s reasonable compliance with regulatory requirements. 
 3.5 Excluded
Securities. The right of first refusal contained in this Section 3 shall not apply to the following: (a) the issuance by the Company of up to an aggregate of 25,000,000 Common Shares to officers, directors or employees of, or
consultants or contractors to, the Company pursuant to a share grant, option plan, purchase plan, purchase agreement, or other share incentive program approved by the Company’s Board of Directors of such person; (b) the issuance of
Securities in connection with the acquisition of a third party, by amalgamation, merger or acquisition of more than fifty-one percent (51%) of the outstanding shares or substantially all of the assets of such third party; (c) the issuance
of Common Shares of the Company upon conversion of the Preferred Shares or upon conversion or exercise of any Security which was not subject to the right of first refusal set forth in this Section 3 or for which the right of first refusal was
not exercised; (d) the issuance of Securities pursuant to any bank, leasing or other financing arrangements; or (e) the issuance of any additional shares the issuance of which is unanimously approved by the Board of Directors of the
Company. 
 3.6 Termination. The right of first refusal contained in this Section 3 shall terminate as follows:

 (a) as to a Major Series A Investor, the earliest of: (i) the time when such Series A Investor
ceases to own at least 500,000 shares of Registrable Securities, (ii) the consummation of a Qualified IPO, and (iii) six (6) years after the Initial Closing; and 
  

 12 

 (b) as to a Major Series B Investor or Major Series C Investor, the
earliest of: (i) the time when such Major Series B Investor or Major Series C Investor, as the case may be, ceases to own at least 250,000 shares of Registrable Securities, (ii) the consummation of a Qualified IPO, and (iii) six
(6) years after the Initial Closing. 
 3.7 Assignment. The rights specified in this Section 3 may not be
assigned except (a) to a purchaser acquiring (i) not less than 500,000 shares of Registrable Securities from a Major Series A Investor; (ii) not less than 250,000 shares of Registrable Securities from a Major Series B
Investor; or (iii) not less than 250,000 shares of Registrable Securities from a Major Series C Investor; (b) to the partners or retired partners or members or retired members of a Major Investor; (c) pursuant to an inter vivos
transfer to Major Investor’s ancestors, descendants or spouse or to a trustee for their benefit; or (d) to a successor entity to a Major Investor pursuant to a reorganisation or recapitalisation of such Major Investor; provided,
however, that the Company receives notice within twenty (20) days following such assignment. 
 SECTION 4

 FINANCIAL INFORMATION 
 4.1 Financial Information. The Company will deliver to each of the Major Investors: 
 (a) As soon as practicable after the end of each fiscal year, but in any event within 120 days after the end of the fiscal year, audited consolidated balance sheet of the Company and its subsidiaries, if
any, as of the end of such fiscal year, and audited consolidated statements of income and cash flow of the Company and its subsidiaries, if any, for such year, prepared in accordance with generally accepted accounting principles
(“GAAP”), all in reasonable detail, and certified by independent public accountants of nationally recognized standing. 
 (b) As soon as practicable after the end of the first, second and third quarterly accounting periods in each fiscal year, and in any event within forty-five (45) days thereafter, unaudited
consolidated balance sheets, profit and loss statements and cash flow analyses of the Company and its subsidiaries, if any, as of the end of each such quarterly period, and for the current fiscal year to date, prepared in accordance with GAAP
(except that such financial statements may (i) be subject to normal year-end audit adjustments and (ii) not contain all notes thereto that may be required in accordance with GAAP); and 
 4.2 Additional Rights for the Major Series B Investors and Major Series C Investors. The Company will deliver to each of the
Major Series B Investors and Major Series C Investors: 
 (a) As soon as practicable, but in any event thirty
(30) days before the end of each fiscal year, a budget and business plan for the next fiscal year (collectively, the “Budget”), approved by the Board of Directors and prepared on a monthly basis, including balance sheets,
income statements, and statements of cash flow for such months and, promptly after prepared, any other budgets or revised budgets prepared by the Company. 
 4.3 Additional Rights for the Major Series C Investors. The Company will deliver to each of the Major Series C Investors: 
 (a) As soon as practicable, but in any event within thirty (30) days of the end of each month, an unaudited income
statement for such month, and an unaudited balance sheet as of the end of such month in such format and at the level of details that are customarily delivered to the Board of Directors of the Company or, in the event such statements are not provided
to the Board of Directors within the said period, the Chief Executive Officer and Chief Financial Officer of the Company for review, all prepared substantially in accordance with GAAP (except that such financial statements may (i) be subject to
normal quarter-end and year-end audit adjustments and (ii) not contain all notes thereto that may be required in accordance with GAAP). 
  

 13 

 4.4 Inspection. 
 (a) Each Major Investor shall have standard inspection rights as prescribed under applicable laws and the Bye-Laws of the
Company, as may be amended from time to time. 
 (b) In accordance with the terms and provisions of the
Company’s Bye-laws (as may be amended from time to time) and applicable laws, the Company shall permit each Major Series C Investor to visit and inspect the Company’s properties; examine its books of account and records; and discuss the
Company’s affairs, finances, and accounts with its officers, during normal business hours of the Company as may be reasonably requested by such Major Series C Investor. 
 4.5 Assignment. The rights specified in this Section 4 may not be assigned except (a) to a purchaser acquiring (i) not
less than 500,000 shares of Registrable Securities from a Major Series A Investor; (ii) not less than 250,000 shares of Registrable Securities from a Major Series B Investor; or (iii) not less than 250,000 shares of Registrable Securities
from a Major Series C Investor; (b) to the partners or retired partners or members or retired members of a Major Investor; (c) pursuant to an inter vivos transfer to Major Investor’s ancestors, descendants or spouse or to a trustee
for their benefit; or (d) to a successor entity to a Major Investor pursuant to a reorganisation or recapitalisation of such Major Investor; provided, however, that the Company receives notice within twenty (20) days
following such assignment. 
 4.6 Termination. The covenants set forth in this Section 4 shall terminate and be of
no further force or effect as follows: 
 (a) as to a Major Series A Investor, the earlier of: (i) the
time when such Series A Investor ceases to own at least 500,000 shares of Registrable Securities, or (ii) the consummation of a Qualified IPO; and 
 (b) as to a Major Series B Investor or Major Series C Investor, the earlier of: (i) the time when such Major
Series B Investor or Major Series C Investor, as the case may be, ceases to own at least 250,000 shares of Registrable Securities, or (ii) the consummation of a Qualified IPO. 
 SECTION 5 
 ADDITIONAL COVENANTS

 5.1 Series C Director. 
 (a) For so long as Sequoia Capital (as defined in the Series C Purchase Agreement) or its affiliates holds at least a
majority of the then outstanding shares of Series C Shares, all holders of Series C Shares shall cast their votes in any circumstances in which a Series C Director (as defined in the Company’s Bye-Laws) is to be elected, in favour of one
(1) individual designated by Sequoia Capital (the “Sequoia Designee”) as the Series C Director in accordance with the Company’s Bye-Laws. As of the Initial Closing, the Sequoia Designee who shall be the Series C Director
shall initially be Mark A. Stevens. 
 (b) So long as Sequoia Capital is entitled to designate the Sequoia
Designee pursuant to Section 5.1(a) above, in the event of any vacancy of the Series C Director on the Board of Directors, each Holder will vote or act with respect to its Series C Shares so as to fill such vacancy with a new Sequoia Designee
designated by Sequoia Capital. 
 (c) So long as Sequoia Capital is entitled to designate the Sequoia Designee
pursuant to Section 5.1(a) above, each Holder agrees that no Series C Director may be removed from the Board of Directors without the approval of Sequoia Capital. 
 (d) The Company agrees, within the requirements of applicable law, to ensure that the terms and conditions of this
Section 5.1 are effective and that Sequoia Capital enjoy the benefits of this provision. Such actions include, without limitation, the use of the Company’s reasonable best efforts to cause the nomination, appointment and election of the
Sequoia Designee as the Series C Director. 
  

 14 

 5.2 Meetings of the Board of Directors. Unless otherwise determined by the vote of a
majority of the directors then in office, the Board of Directors shall meet at least quarterly in accordance with an agreed-upon schedule. 
 5.3 Successor Indemnification. If the Company or any of its successors or assignees consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of
such consolidation or merger, then to the extent necessary, proper provision shall be made so that the successors and assignees of the Company assume the obligations of the Company with respect to indemnification of members of the Board of Directors
as in effect immediately before such transaction, whether such obligations are contained in the Company’s Bye-laws or elsewhere, as the case may be. 
 5.4 Board Expenses. The Company shall reimburse the nonemployee directors for all reasonable out-of-pocket travel expenses incurred in connection with attending meetings of the Board of Directors.

 5.5 Insurance. The Company shall use its commercially reasonable efforts to obtain, within thirty (30) days of
the date hereof, from financially sound and reputable insurers, Directors and Officers insurance and Errors and Omissions insurance in amounts satisfactory to the Board of Directors, and will use commercially reasonable efforts to cause such
insurance policies to be maintained until such time as the Board of Directors determines that such insurance should be discontinued. 
 5.6 Termination. The covenants set forth in this Section 5, except for Section 5.3, shall terminate and be of no further force or effect upon the consummation of a Qualified IPO. 
 SECTION 6 
 MISCELLANEOUS 
 6.1 Governing Law. This Agreement shall be governed in all respects by the
internal laws of the State of California as applied to agreements entered into among California residents to be performed entirely within California, without regard to principles of conflicts of law. 
 6.2 Additional Series C Investors. In the event the Company issues Series C Preferred to the Additional Series C
Investors, each of the Additional Series C Investors shall become a Series C Investor hereunder and be entitled to assume all of the rights and obligations of an Investor under this Agreement, provided that each Additional Series C
Investor shall execute a counterpart signature page to signify its intention to be bound by the provisions of this Agreement. 
 6.3 Successors and Assigns. Except as otherwise provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto.

 6.4 Entire Agreement; Amendment. This Agreement and the other documents delivered pursuant hereto constitute the full
and entire understanding and agreement between the parties with regard to the subjects hereof and thereof. This Agreement and any provisions hereof and the observation of any rights provided herein may be amended, waived, discharged or terminated by
agreement in writing signed by the Company and by the Holders of a majority of the Registrable Securities then outstanding; provided that any provision hereof may be waived by any waiving party on such party’s own behalf, without the consent of
any other party. Notwithstanding the foregoing, this Agreement may not be amended or terminated and the observance of any term hereof may not be waived with respect to any Investor without the written consent of such Investor, unless such amendment,
termination, or waiver applies to all Investors in the same fashion (it being agreed that a waiver of the provisions of Section 3 with respect to a particular transaction shall be deemed to apply to all Major Investors in the same fashion if
such waiver does so by its terms, notwithstanding the fact that certain Major Investors may

  

 15 

 
nonetheless, by agreement with the Company, purchase securities in such transaction). The Company shall give prompt notice of any amendment or termination hereof or waiver hereunder to any party
hereto that did not consent in writing to such amendment, termination, or waiver. Any amendment, termination, or waiver effected in accordance with this Section 6.4 shall be binding on all parties hereto, regardless of whether any such party
has consented thereto. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.

 6.5 Notices, Etc. All notices and other communications required or permitted hereunder shall be in writing and shall
be mailed by registered or certified mail, postage prepaid, or otherwise delivered by hand or by messenger, addressed (a) if to an Investor, to such Investor’s address set forth on Exhibit A, or to such other address as
Investor shall have furnished to the Company in writing, or (b) if to any other holder of any Restricted Securities, to such address as such holder shall have furnished the Company in writing, or, until any such holder so furnishes an address
to the Company, then to the address of the last holder of such Restricted Securities who has so furnished an address to the Company, or (c) if to the Company, one copy to its address set forth on the cover page of this Agreement and addressed
to the attention of the Corporate Secretary, or to such other address as the Company shall have furnished to the Investors. If notice is provided by mail, notice shall be deemed to be given upon proper deposit in the mail (and if outside the United
States, sent by airmail). 
 6.6 Delay or Omissions. No delay or omission to exercise any right, power or remedy accruing
to any holder of any Restricted Securities upon any breach or default of the Company under this Agreement shall impair any such right, power or remedy of such Holder, nor shall it be construed to be a waiver of any such breach or default, or an
acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit,
consent or approval of any kind or character on the part of any Holder of any breach or default under this Agreement, or any waiver on the part of any Holder of any provisions or conditions of this Agreement, must be in writing and shall be
effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any holder, shall be cumulative and not alternative. 
 6.7 Expenses. Except as provided in Section 2, the Company and each Investor shall bear its own expenses and legal fees incurred
on its behalf with respect to this Agreement and the transactions contemplated hereby. 
 6.8 Counterparts. This
Agreement may be executed in any number of counterparts, all of which together shall constitute one instrument, and each of which may be executed by less than all of the parties to this Agreement. 
 6.9 Severability. In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be
illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision; provided that no such severability shall be effective if it materially changes the economic benefit of this Agreement to any party.

 6.10 Conflict. In the event that any provision of this Agreement conflicts with or is inconsistent with the terms of
the Company’s Bye-Laws as in effect from time to time as such Bye-laws relate to the parties hereto, the terms of this Agreement shall prevail. 
 6.11 Aggregation of Shares. All shares of Registrable Securities held or acquired by affiliates shall be aggregated together for the purpose of determining the availability of any rights under this
Agreement (including, without limitation, for purposes of determining the status of any Major Investor). 
  

 16 

 The foregoing Agreement is hereby executed as of the date first above written. 

COMPANY: 
 ALPHA AND OMEGA
 SEMICONDUCTOR LIMITED 

 

	
	
	 /s/ Mike F. Chang
 Mike F. Chang, Chief Executive Officer

  
 [Signature Page to Amended and Restated Investors Rights Agreement] 

 The foregoing agreement is hereby executed as of the date first above written. 

INVESTORS: 
  

	
	 By:                                       
                                         
          

	
	 Title:                                      
                                         
        

  
 [Signature Page to Amended and Restated Investors Rights Agreement] 

 EXHIBIT A 
 SERIES A INVESTORS 
  

			
	 Name
	  	Number of Series A
Preferred Shares
	 Fortune Venture Capital Corp.
 3/F, No. 76 Sec 2, Tun-Hwa South Road
 Taipei, Taiwan, R.O.C.
	  	1,500,000
		
	 UMC Capital Corporation
 One Capital Place, Shedden Road
 P.O. Box 1034GT, Grand Cayman, Cayman Islands
	  	1,500,000
		
	 Trinity Overseas Holdings Limited
 No. 18, Creation Road l, SBIP
 Hsin-Chu, Taiwan, R.O.C.
	  	2,000,000
		
	 Wu, Po-Chuan
 5F-2, No. 58, Section II
 Ho-Pei Road, Taichung, Taiwan, R.O.C.
	  	100,000
		
	 Cheng, Hsin-Chia
 No. 153, Ta-Tung Road
 Hsinchu, Taiwan, R.O.C.
	  	50,000
		
	 Wang, Long-Chia
 No. 4, Creation Road III
 Science-Based Industrial Park
 Hsinchu, Taiwan, R.O.C.
	  	50,000
		
	 Chang, Mu-Tien
 No. 3 Li-Hsin Road II
 Science-Based Industrial Park
 Hsin-Chu City, 30077
 Taiwan, R.O.C.
	  	50,000
		
	 Wei, Chiu-Chi
 7F-12, No. 130 Ssu-Wei Road
 Hsinchu, Taiwan
	  	50,000
		
	 Chiu, Cheng Wei
 No. 3 Li-Hsin Road II
 Science-Based Industrial Park
 Hsin-Chu City
 Taiwan 30077, R.O.C.
	  	50,000
		
	 Huang, Day-Chuang
 No. 3 Li-Hsin Road II
 Science-Based Industrial Park
 Hsin-Chu City 30077
 Taiwan, R.O.C.
	  	50,000
		
	 Chiang, Ming-Feng
 No. 3 Li-Hsin Road II
 Science-Based Industrial Park
 Hsin-Chu City
 Taiwan 30077, R.O.C.
	  	50,000

			
	 Name
	  	Number of Series A
Preferred Shares
	 Hwang, Ya-Yung
 No. 3 Li-Hsin Road II
 Science-Based Industrial Park
 Hsin-Chu City, 30077
 Taiwan, R.O.C.
	  	50,000
		
	 Lai, Cheng-Han
 No. 3 Li-Hsin Road II
 Science-Based Industrial Park
 Hsin-Chu City 30077, Taiwan, R.O.C.
	  	50,000
		
	 Liu, Yu-Lin
 No. 3 Li-Hsin Road II
 Science-Based Industrial Park
 Hsin-Chu City 30077, Taiwan, R.O.C.
	  	50,000
		
	 Richmond Holdings Global Limited
 P.O. Box 3340, Road Town
 British Virgin Islands
	  	500,000
		
	 Universal Microelectronics Co., Ltd.
 No. 3, 27th Road, Taichung Industrial Park
 Taichung, Taiwan, R.O.C.
	  	2,000,000
		
	 Sun, Kuei Chih
 2F., No. 20-1, Lane 6
 Hsin-Chun Street
 Taipei, Taiwan, R.O.C.
	  	60,000
		
	 Chi, Hung-Cheng
 10th floor, No. 57, Sec. 4
 Sin Yi Road
 Taipei, Taiwan, R.O.C.
	  	60,000
		
	 Chien, Jui-Feng
 2F, No. 20-1, Lane 6
 Hsin-Chun Street
 Taipei, Taiwan, R.O.C.
	  	10,000
		
	 Lin, Hsin-Ta
 3/F, No. 17, Lane 160
 Sec. 3, Minchuen E. Road
 Taipei, Taiwan, R.O.C.
	  	50,000
		
	 Lin, Wan-I
 1F, No. 2, Alley 13, Lane 18, Sec. 2
 Ho-Ping E. Road
 Taipei, Taiwan, R.O.C.
	  	150,000
		
	 Hung, Ling-Lian
 2F, No. 7, Alley 7, Rung Hua Yi Road
 Peitou, Taipei, Taiwan, R.O.C.
	  	70,000
		
	 Wang, Sheng-Jui
 11F-3, No. 43, Alley 6, Lane 182
 Sec. 4, Chenggung Road
 Taipei, Taiwan, R.O.C.
	  	100,000

			
	 Name
	  	Number of Series A
Preferred Shares
	 Advantech Investment Fund-B Co., Ltd.
 3rd floor, 108, Sec. 1, Tun Hwa S. Road
 Taipei, Taiwan, R.O.C.
	  	350,000
		
	 Ta Ya Venture Capital Co., Ltd.
 3rd floor, 108, Sec. 1, Tun Hwa S. Road,
 Taipei, Taiwan, R.O.C.
	  	350,000
		
	 SinoStar Venture Capital Co. Ltd.
 3rd floor, 108, Sec. 1, Tun Hwa S. Road,
 Taipei, Taiwan, R.O.C.
	  	350,000
		
	 NCTU Spring Venture Capital Co. Ltd.
 3rd floor, 108, Sec. 1, Tun Hwa S. Road,
 Taipei, Taiwan, R.O.C.
	  	450,000
		
	 Total:
	  	10,100,000

 EXHIBIT B 
 SERIES B INVESTORS 
  

			
	 Name
	  	Number of Series B
Preferred Shares
	 ADVANCED E-Tech Corp.
 3rd
Floor, Omar Hodge Building
 Wickhamas Cay 1
 P.O. Box 362
 Road Town, Tortola, BVI
	  	250,000
		
	 Frontek Technology Corporation
 (formerly Jaenn Corporation)
 5F, No. 128, Lane 235
 Banuchiau Road, Shindian City
 Taipei, Taiwan 231, R.O.C.
	  	50,000
		
	 Konnect Technology Inc.
 7F-2,
No. 77, Hsin Tai Wu Road
 Section 1
 His-Chih, Taipei Hsien
 Taiwan, R.O.C.
	  	250,000
		
	 Promate Electronic Co. Ltd.
 4F, 32, Section 1, Huan Shan Road
 Nei Hu, Taipei 114
 Taiwan, R.O.C.
	  	250,000
		
	 Universal Microelectronics Co., Ltd.
 No. 3, 27th Road
 Taichung Industrial Park
 Taichung, Taiwan, R.O.C.
	  	75,000
		
	 Fang-Jy Chung
 21
Ashbrook
 Irvine, CA 92604
	  	100,000
		
	 Chiu-Pi Chiang
 4F,
No. 145 Jungyi Street
 Taipei, Taiwan, R.O.C.
	  	25,000
		
	 Hantech International Venture Capital Corporation
 18F-1, 333 Keelung Rd. Section 1
 Taipei 110, Taiwan, R.O.C.
	  	1,000,000
		
	 Quanta Computer Inc.
 No. 188, Wen Hwa 2nd Rd.,
 Kuei Shan Hsiang, Tao Yuan Shien
 Taiwan,
R.O.C.
	  	400,000
		
	 Lam Pak Lee
 No. 188, Wen
Hwa 2nd Rd.,
 Kuei Shan Hsiang, Tao Yuan Shien
 Taiwan, R.O.C.

	  	100,000
		
	 Harbinger II (BVI) Venture Capital Corp.
 7F, No. 187, Tiding Blvd., Sec. 2, Neihu
 Taipei, Taiwan 114, R.O.C.
	  	380,952

			
	 Name
	  	Number of Series B
Preferred Shares
	 CMF Technology Fund I Ltd.
 Room 1611, 16F West Tower, Shun Tak Center
 168-200 Connught Road
 Central, Hong Kong
	  	833,333
		
	 Pacific Venture Management, LDC
 555 Twin Dolphin Drive, Ste. 310
 Redwood Shores, CA 94065
	  	238,095
		
	 Pacific Technology Partners, L.P.
 555 Twin Dolphin Drive, Ste. 310
 Redwood Shores, CA 94065
	  	600,310
		
	 Pacific Technology Advisors, LDC
 555 Twin Dolphin Drive, Ste. 310
 Redwood Shores, CA 94065
	  	123,500
		
	 Pacific United Technology, L.P.
 555 Twin Dolphin Drive, Ste. 310
 Redwood Shores, CA 94065
	  	300,000
	 Total:
	  	4,976,190

 EXHIBIT C 
 SERIES C INVESTORS 
  

			
	 Name
	  	Number of Series C
Preferred Shares
	 Sequoia Capital Growth Fund III AIV, L.P.
 c/o Sequoia Capital
 Attn: Chief Financial Officer
 3000 Sand Hill Road
 Building 4, Suite 180
 Menlo Park, CA 94025
 Fax: (650) 854-2977
	  	5,646,600
		
	 Sequoia Capital Growth Partners III, L.P.
 c/o Sequoia Capital
 Attn: Chief Financial Officer
 3000 Sand Hill Road
 Building 4, Suite 180
 Menlo Park, CA 94025
 Fax: (650) 854-2977
	  	61,800
		
	 Sequoia Capital Growth III Principals Fund
 c/o Sequoia Capital
 Attn: Chief Financial Officer
 3000 Sand Hill Road
 Building 4, Suite 180
 Menlo Park, CA 94025
 Fax: (650) 854-2977
	  	291,600
		
	 Harbinger II (BVI) Venture Capital Corp.
 7F, No. 187, Tiding Blvd., Sec. 2, Neihu
 Taipei, Taiwan 114, R.O.C.
	  	200,000
		
	 Universal Microelectronics Co., Ltd.
 No. 3, 27th Road, Taichung Industrial Park
 Taichung, Taiwan, R.O.C.
	  	100,000
		
	 ADVANCED E-Tech Corp.
 3rd Floor, Omar Hodge Building
 Wickhamas Cay 1
 P.O. Box 362
 Road Town, Tortola, BVI
	  	24,000
		
	 Konnect Technology Inc.
 7F-2, No. 77, Hsin Tai Wu Road
 Section 1
 His-Chih, Taipei Hsien
 Taiwan, R.O.C.
	  	24,000
		
	 Total
	  	6,348,0002000 Share Plan

 Exhibit 10.1 
 ALPHA AND OMEGA SEMICONDUCTOR LIMITED 
 2000 SHARE
PLAN 
 (Amended as of January 9, 2008) 
 1. Purposes of the Plan. The purposes of this 2000 Share Plan are to attract and retain the best available personnel, to provide
additional incentive to the Employees, Directors and Consultants of the Company and its Subsidiaries, to promote the success of the Company’s business, and to enable the Employees to share in the growth and prosperity of the Company by
providing them with an opportunity to purchase shares in the Company. 
 Options granted hereunder may be either Incentive Stock
Options or Nonstatutory Stock Options, as determined by the Administrator at the time of grant and as reflected in the terms of the written share option agreement. Share Purchase Rights may also be granted under the Plan as determined by the
Administrator. 
 2. Definitions. As used herein, the following definitions shall apply: 
 (a) “Administrator” shall mean the Board or the Committee as shall be administering the Plan in accordance
with Section 4 hereof. 
 (b) “Applicable Laws” shall mean the requirements relating to the
administration of stock (or share) option plans under U.S. state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which the Common Shares are listed or quoted and the applicable laws of any
other country or jurisdiction where Options or Share Purchase Rights are granted under the Plan. 
 (c)
“Board” shall mean the Board of Directors of the Company. 
 (d) “Code” shall
mean the Internal Revenue Code of 1986 (United States), as amended. 
 (e) “Common Shares” shall
mean the Common Shares of the Company. 
 (f) “Company” shall mean Alpha and Omega Semiconductor
Limited, an Islands of Bermuda company. 
 (g) “Companies Act” shall mean the Companies Act 1981
(Bermuda), as amended. 
 (h) “Committee” shall mean a committee appointed by the Board in
accordance with Section 4 hereof, if one is appointed. 
 (i) “Consultant” shall mean any
person or entity who is engaged by the Company, its Parent or any Subsidiary to render consulting or advisory services. 
 (j) “Director” shall mean a member of the Board. 
 (k) “Disability”
shall mean total and permanent disability as defined in Section 22(e)(3) of the Code. 
 (l)
“Employee” shall mean any person employed by the Company or any Parent or Subsidiary of the Company or its successor and shall include Officers and Directors other than any Non-Employee Director. An Employee shall not cease to be an
Employee in the case of (i) any leave of absence approved by the Company or (ii) any transfer between locations of the Company or between the Company, its Parent, any Subsidiary, or any successor. For purposes of Incentive Stock Options,
no such leave may exceed ninety days unless reemployment upon expiration of such leave is guaranteed by statute or contract. If reemployment upon expiration of a leave of absence approved by the Company is not so guaranteed, any Incentive Stock
Option held by the Optionee shall cease to be treated as an Incentive Stock Option and shall be treated for tax purposes as a Nonstatutory Stock Option. Neither service as a Director nor payment of a Director’s fee by the Company shall be
sufficient to constitute “employment” by the Company. 

 (m) “Exchange Act” shall mean the Securities Exchange Act
of 1934, as amended, or any successor legislation. 
 (n) “Incentive Stock Option” shall mean an
Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code. 
 (o) “Non-Employee Director” shall mean a director who is a “Non-Employee Director,” as such term is defined under Rule 16b-3(b)(3)(i) promulgated pursuant to the Exchange Act and any applicable releases and
opinions of the Securities and Exchange Commission. 
 (p) “Nonstatutory Stock Option” shall
mean an Option which is not an Incentive Stock Option. 
 (q) “Officer” shall mean a person who
is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder. 
 (r) “Option” shall mean a share option granted pursuant to the Plan. 
 (s) “Option Agreement” shall mean a written agreement between the Company and an Optionee in such form or forms as the Administrator (subject to the terms and conditions of the Plan) may
from time to time approve, evidencing an Option. 
 (t) “Option Exchange Program” shall mean a
program whereby outstanding Options are exchanged for Options with a lower exercise price. 
 (u)
“Optioned Shares” shall mean the Common Shares subject to an Option or a Share Purchase Right. 
 (v) “Optionee” shall mean the holder of an outstanding Option or Share Purchase Right granted under the Plan. 
 (w) “Parent” shall mean a “parent corporation,” whether now or hereafter existing, as defined in Sections 424(e) and (g) of the Code. 
 (x) “Plan” shall mean this Alpha and Omega Semiconductor Limited 2000 Share Plan. 
 (y) “Registration Date” shall mean the effective date of the first registration statement which is filed by
the Company and declared effective pursuant to Section 12(g) of the Exchange Act, with respect to any class of the Company’s securities. 
 (z) “Restricted Shares” shall mean Common Shares acquired pursuant to a grant of a Share Purchase Right. 
 (aa) “Securities Act” shall mean the Securities Act of 1933 (United States), as amended, or any successor
legislation. 
 (bb) “Service Provider” shall mean an Employee, Consultant or Non-Employee
Director. 
 (cc) “Share” or “Shares” shall mean one or more shares of the
Common Shares, as adjusted in accordance with Section 13 of the Plan. 
 (dd) “Share Purchase
Agreement” shall mean an agreement in such form or forms as the Administrator (subject to the terms and conditions of the Plan) may from time to time approve, which is to be executed as a condition of purchasing Optioned Shares upon
exercise of an Option or a Share Purchase Right. 
 (ee) “Share Purchase Right” shall mean a
right to purchase Common Shares pursuant to Section 12 hereof. 
 (ff) “Subsidiary” shall
mean a subsidiary corporation, whether now or hereafter existing, as defined in Sections 424(f) and (g) of the Code. 
 3. Shares Subject to the Plan. Subject to the provisions of Section 12 of the Plan, the maximum aggregate number of Shares which may be optioned and sold under the Plan is ten million eight hundred fifty thousand
(10,850,000) Shares. The Shares may be authorised, but unissued or reacquired Shares other than reacquired Shares delivered pursuant to Section 7(c)(iv) hereof as payment of consideration in the exercise of an option. 
  

 2 

 If an Option or Share Purchase Right expires or becomes unexercisable for any reason without
having been exercised in full, or is surrendered pursuant to an Option Exchange Program, the unpurchased Shares which were subject thereto shall, unless the Plan shall have been terminated, return to the Plan and become available for future grant or
sale under the Plan. However, Shares that have actually been issued under the Plan, upon exercise of either an Option or Share Purchase Right, shall not be returned to the Plan and shall not become available for future grant or sale under the Plan,
except that if Restricted Shares are repurchased by the Company at their original purchase price and cancelled, such Shares (which will then be authorised but unissued Shares) shall become available for future grant or sale under the Plan.

 The Company intends that as long as it is not subject to the reporting requirements of Section 13 or 15(d) of the
Exchange Act, and is not an investment company registered or required to be registered under the Investment Company Act of 1940, as amended, all offers and sales of Options and Common Shares hereunder shall be exempt from registration under the
provisions of Section 5 of the Securities Act, and the Plan shall be administered in such a manner so as to preserve such exemption. The Company intends for the Plan to constitute a written compensatory benefit plan within the meaning of
Rule 701(b) of 17 CFR Section 230.701 (“Rule 701”) promulgated by the Securities and Exchange Commission pursuant to the Securities Act. Unless otherwise designated by the Administrator or the Committee at the time an
Option is granted, all options granted and Shares sold hereunder are intended to be granted in reliance on Rule 701. 
 4.
Administration of the Plan. 
 (a) Plan Administration. The Plan shall be administered by the
Administrator. If the Committee is the Administrator, it shall be constituted to comply with Applicable Laws. 
 (b) Power of the Administrator. Subject to the provisions of the Plan and, in the case of the Committee being the Administrator, the specific duties delegated by the Board to the Committee, and subject to the approval of any relevant
authorities, the Administrator shall have the authority in its discretion: 
 (i) to determine the fair market
value of the Common Shares in accordance with Section 7 hereof, 
 (ii) to select the Service Providers to
whom Options (including Incentive Stock Options and Nonstatutory Stock Options) and Share Purchase Rights may be granted hereunder from time to time; 
 (iii) to determine the number of Shares to be covered by each such grant of Options and Share Purchase Rights hereunder; 
 (iv) to determine the terms and provisions of each Option Agreement (each of which need not be identical with the terms of
other Option Agreements) and, with the consent of the holder thereof, to modify or amend each Option Agreement; 
 (v) to approve other agreements for use under the Plan, including without limitation Share Purchase Agreements (each of which need not be identical to other Share Purchase Agreements), and with the consent of the holder thereof, to modify
or amend each such agreement; 
 (vi) to determine the terms and conditions of any Option or Share Purchase Right
granted hereunder, including without limitation, the exercise price, the type of consideration, the time or times when such Option or Share Purchase Right may be exercised (which may be time- or performance-based), any vesting acceleration or waiver
of forfeiture restrictions, and any restriction or limitation regarding such Option or Share Purchase Right or the Common Shares relating thereto, based in each case on such factors as the Administrator, in its sole discretion, shall determine;

 (vii) to determine whether and under what circumstances an Option may be settled in cash under the Plan;

 (viii) to reduce the exercise price of any Option to the then current fair market value of Common Shares if
such fair market value has declined since the date of the Option was granted; 
 (ix) to initiate an Option
Exchange Program; 
  

 3 

 (x) to allow Optionees to satisfy withholding tax obligations by electing to
have the Company withhold from the Shares to be issued upon exercise of an Option or Share Purchase Right that number of Shares having a fair market value equal to the amount required be withheld; the fair market value of the Shares to be withheld
shall be determined on the date that the amount of tax to be withheld is to be determined; all elections by Optionees to have Shares withheld for this purpose shall be made in such form and under such conditions as the Administrator may deem
necessary or advisable; 
 (xi) to prescribe, amend and rescind rules and regulations relating to the Plan,
including rules and regulations relating to any sub-plans established for the purpose of qualifying for preferred tax treatment under foreign tax laws, or for the purpose of satisfying the requirements of all Applicable Laws; 
 (xii) to construe and interpret the Plan, the Option Agreements or any other agreements entered into with respect to the
grant or exercise of Options or Share Purchase Rights hereunder; 
 (xiii) to authorise any person to execute on
behalf of the Company any instrument required to effectuate the grant of an Option or Share Purchase Right previously granted by the Administrator or to take such other actions as may be necessary or appropriate with respect to the Company’s
rights pursuant to Options or agreements relating to the grant or exercise thereof; and 
 (xiv) to make such
other determinations and establish such other procedures as it deems necessary or advisable for the administration of the Plan. 
 (c) Effect of the Administrator’s Decision. All decisions, determinations and interpretations of the Administrator shall be final and binding on all Optionees and any other holders of
Options or Share Purchase Rights. 
 5. Eligibility. 
 (a) Nonstatutory Stock Options and Share Purchase Rights may be granted to Service Providers. Incentive Stock Options may be
granted only to Employees. An Employee who has been granted an Option may, if such Employee is otherwise eligible, be granted additional Options. A Service Provider who has been granted a Nonstatutory Stock Option or Share Purchase Right may, if
such Service Provider is otherwise eligible, be granted additional Nonstatutory Stock Options or Share Purchase Rights. 
 (b) Neither the Plan nor any Option or Share Purchase Right shall confer upon any Optionee any right with respect to continuing the Optionee’s relationship as a Service Provider with the Company, nor shall it interfere in any way with
its right or the Company’s right to terminate such relationship at any time, with or without cause. 
 6. Term of
Plan. This Plan shall become effective upon the earlier to occur of its adoption by the Board or its approval by vote of a majority of the outstanding shares of the Company entitled to vote on the adoption of the Plan. This Plan shall continue
in effect for a term of ten (10) years unless sooner terminated in accordance with the terms and provisions of the Plan. 
 7. Option Exercise Price and Consideration. 
 (a) Exercise Price. The exercise price per
Share for the Shares to be issued pursuant to the exercise of an Option shall be such price as is determined by the Administrator in accordance with Section 7(b); provided, however, that such price shall in no event be less than
eighty-five percent (85%) with respect to Nonstatutory Stock Options, and one hundred percent (100%) with respect to Incentive Stock Options, of the fair market value per Share and, in any event, shall not be less than the par value of the
Share. In the case of an Incentive Stock Option granted to an Employee or a Service Provider who, at the time such Option is granted, owns shares (as determined under Section 424(d) of the Code) constituting more than ten percent (10%) of
the total combined voting power of all classes of shares of the Company or its Parent or Subsidiaries, the exercise price per Share shall be no less than one hundred ten percent (110%) of the fair market value per Share. Notwithstanding the
foregoing, Options may be granted with an exercise price per Share other than as required above pursuant to a merger or other similar corporate transactions. 
  

 4 

 (b) Fair Market Value. Subject always to the minimum requirements of
Applicable Laws, the fair market value per Share shall be determined by the Administrator in its sole discretion, exercised in good faith; provided, however, that where there is a public market for the Common Shares, the fair market
value per Share shall be the average of the closing bid and asked prices of the Common Shares on the date of grant or the last market trading day prior to the date of grant, as reported in The Wall Street Journal (or, if not so reported, as
otherwise reported by the National Association of Securities Dealers Automated Quotations (“NASDAQ”) System), or, in the event the Common Shares is listed on a stock exchange or on the NASDAQ System, the fair market value per Share
shall be the closing price on the exchange or on the NASDAQ System as of the date of grant or the last listed trading day prior to the date of grant, as reported in The Wall Street Journal. 
 (c) Payment of Consideration. The consideration to be paid for the Shares to be issued upon exercise of an Option,
including the method of payment, shall be determined by the Administrator and may consist entirely of cash, check, promissory notes, Shares held by the Optionee for the requisite period necessary to avoid a charge to the Company’s earnings for
financial reporting purposes which have a fair market value on the date of surrender equal to the aggregate exercise price of the Shares as to which said Option shall be exercised, or any combination of such methods of payment. Subject to
subparagraphs (i) through (iv) hereto, utilisation of Shares as the method of payment may be completed by either (a) the tender of Shares then held by the Optionee, or (b) the withholding of Shares which would otherwise be issued
pursuant to an Option pursuant to broker-dealer sale and remittance procedure described in subparagraph (iii) hereto. In making its determination as to the type of consideration to accept, the Board shall consider if acceptance of such
consideration is deemed to be such as may be reasonably expected to benefit the Company and if such consideration is of equivalent value to the Shares to be issued. 
 (i) If the consideration for the exercise of an Option is a promissory note, it shall be a full recourse promissory note
executed by the Optionee, bearing interest at a rate which shall be sufficient to preclude the imputation of interest under the applicable provisions of the Code and acceptable subject to the restrictions placed upon the Company with respect to the
rendering of financial assistance for the purchase of acquiring Shares by the Companies Act. Until such time as the promissory note has been paid in full, the Company may retain the Shares purchased upon exercise of the Option in escrow as security
for payment of the promissory note. 
 (ii) If the consideration for the exercise of an Option is the surrender
of previously acquired and owned Shares, the Optionee will be required to make representations and warranties satisfactory to the Company regarding his title to the Shares used to effect the purchase, including, without limitation, representations
and warranties that the Optionee has good and marketable title to such Shares free and clear of any and all liens, encumbrances, charges, equities, claims, security interests, options or restrictions and has full power to deliver such Shares without
obtaining the consent or approval of any person or governmental authority other than those which have already given consent or approval in a form satisfactory to the Company. The value of the Shares used to effect the purchase shall be the fair
market value of those Shares as determined by the Board in its sole discretion, exercised in good faith. 
 (iii)
If the consideration for the exercise of an Option is to be paid through a broker-dealer sale and remittance procedure, the Optionee shall provide (1) irrevocable written instructions to a designated brokerage firm to effect the immediate sale
of the purchased shares and to remit to the Company, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate option price payable for the purchased Shares plus all applicable Federal and State income and
employment taxes required to be withheld by the Company in connection with such purchase and (2) written instructions to the Company to deliver the certificates for the purchased Shares directly to such brokerage firm in order to complete the
sale transaction. 
 (iv) If an Optionee is permitted to exercise an Option by delivering shares of the
Company’s Common Shares, the Option Agreement covering such Option may include provisions authorising the Optionee to exercise the Option, in whole or in part, by: (1) delivering whole shares of the Company’s Common Shares previously
owned by such Optionee (whether or not acquired through the prior exercise of a share option) having a fair market value equal to the option price; and/or (2) directing the

  

 5 

 
Company to withhold from the Shares that would otherwise be issued upon exercise of the Option that number of whole Shares having a fair market value equal to the option price. Shares of the
Company’s Common Shares so delivered or withheld shall be valued at their fair market value on the date of exercise of the Option, as determined by the Administrator. Any balance of the exercise price shall be paid in cash or by check or a
promissory note, each in accordance with the terms of this Section 7. Any Shares delivered or withheld in accordance with this provision shall again become available for purposes of the Plan and for Options subsequently granted thereunder to
the extent permissible pursuant to Section 3 hereof. 
 8. Options. 
 (a) Terms and Provisions of Options. As provided in Section 4 of the Plan and subject to any limitations
specified herein, the Administrator shall have the authority to determine the terms and provisions of any Option granted under the Plan or any agreement required to be executed in connection with the grant or exercise of an Option. Each Option
granted pursuant to the Plan shall be evidenced by an Option Agreement. Options granted pursuant to the Plan are conditioned upon the Company obtaining any required permit or order from appropriate governmental agencies authorising the Company to
issue such Options and Shares issuable upon exercise thereof. 
 (b) Term of Option. The term of an Option
shall be specified in an Option Agreement pertaining thereto and may be up to ten (10) years from the date of grant thereof, except that the term of an Option granted to an Optionee who, at the time the Option is granted, owns shares comprising
more than ten percent (10%) of the total combined voting power of all classes of securities of the Company or its Parent or Subsidiaries, shall be five (5) years from the date of grant thereof or such shorter term as may be provided in the
Option Agreement. 
 (c) Exercise of Option. 
 (i) Procedure for Exercise Rights as Shareholder. Any Option shall be exercisable at such times, in such installments
and under such conditions as may be determined by the Administrator and specified in the Option Agreement pertaining thereto, including performance criteria with respect to the Company and/or the Optionee, and as shall be permissible under the terms
of the Plan. 
 An Option may be exercised in accordance with the provisions of the Plan as to all or any portion of the Shares
then exercisable under an Option, from time to time during the term of the Option. An Option may not be exercised for a fraction of a Share. 
 An Option shall be deemed to be exercised when written notice of such exercise has been given to the Company at its principal business office in accordance with the terms of the Option Agreement by the
person entitled to exercise the Option and, except when the broker-dealer sale and remittance procedure described in Section 7(c)(iii) hereto is used, full payment for the Shares with respect to which the Option is exercised has been received
by the Company, accompanied by an executed Share Purchase Agreement and any other agreements required by the terms of the Plan and/or the Option Agreement. Full payment may consist of such consideration and method of payment allowable under
Section 7 of the Plan. Until the Option is properly exercised in accordance with the terms of this paragraph, no right to vote or receive dividends or any other rights as a shareholder (or member) exist with respect to the Optioned Shares. No
adjustment shall be made for a dividend or other right for which the record date is prior to the date the Option is exercised, except as provided in Section 13 of the Plan. 
 As soon as practicable after any proper exercise of an Option in accordance with the provisions of the Plan, the Company shall, without
transfer or issue tax to the Optionee, deliver to the Optionee at the principal executive office of the Company or such other place as shall be mutually agreed upon between the Company and the Optionee, a certificate or certificates representing the
Shares for which the Option shall have been exercised. The time of issuance and delivery of the certificate(s) representing the Shares for which the Option shall have been exercised may be postponed by the Company for such period as may be required
by the Company, with reasonable diligence, to comply with any applicable listing requirements of any national or regional securities

  

 6 

 
exchange or any law or regulation applicable to the issuance or delivery of such Shares. No Option may be exercised unless the Plan has been duly approved by the shareholders (or members) of the
Company in accordance with Applicable Laws. Notwithstanding anything to the contrary herein, the terms of a Share Purchase Agreement required to be executed and delivered in connection with the exercise of an Option may require the certificate or
certificates representing the Shares purchased upon exercise of an Option to be delivered and deposited with the Company as security for the Optionee’s faithful performance of the terms of its Share Purchase Agreement. 
 Exercise of an Option in any manner shall result in a decrease in the number of Shares which thereafter may be available, both for purposes
of the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised. 
 (ii)
Termination of Relationship as a Service Provider. If an Optionee ceases to be a Service Provider for any reason other than death or disability, such Optionee shall have the right to exercise the Option at any time within thirty
(30) days (or such longer period of time as specified in the Option Agreement) following the date such Optionee ceases to be a Service Provider, to the extent that such Optionee was entitled to exercise the Option at the date of such
termination; provided, however, that no Option shall be exercisable after the expiration of the term set forth in the Option Agreement. To the extent that such optionee was not entitled to exercise the Option at the date of such
termination, or if such Optionee does not exercise such Option (which such Optionee was entitled to exercise) within the time specified herein, the Option shall terminate, and the Shares covered by such Option shall revert to the Plan. 

(iii) Death or Disability of Optionee. If an Optionee ceases to be a Service Provider as a result of death or
Disability, the Option may be exercised at any time within six (6) month following the date of death or Disability, in the case of death, by the Optionee’s estate or by a person who acquired the right to exercise the Option by bequest or
inheritance, or, in the case of Disability, by the Optionee, but in any case only to the extent the Optionee was entitled to exercise the Option at the date of its termination of relationship as a Service Provider; provided, however,
that no Option shall be exercisable after the expiration of the Option term set forth in the Option Agreement. To the extent that such Optionee was not entitled to exercise such Option at the date of its termination of relationship as a Service
Provider as a result of death or Disability or if such Option is not exercised (to the extent it could be exercised) within the time specified herein, the Option shall terminate and revert to the Plan. 
 9. Repurchase of Shares. At the option of the Administrator, the shares to be delivered pursuant to the exercise of any Option
granted to an Employee, Director or Consultant under this Plan may be subject to a right of repurchase in favor of the Company, subject to the terms of the Companies Act, with respect to any Employee, or Director or Consultant whose employment, or
director or consulting relationship with the Company is terminated. 
 10. Limit on Value of Optioned Shares. To the
extent the aggregate fair market value (determined at the time an Option is granted) of the Shares with respect to which Incentive Stock Options are exercisable for the first time by an Optionee during any calendar year under all share plans or
share option plans of the Company, its Parents or its Subsidiaries, if any, exceeds One Hundred Thousand Dollars ($100,000), such Options shall be treated as Nonstatutory Stock Options. For the purpose of this Section 10, Incentive Stock
Options shall be taken into account in the order in which they were granted. The fair market value of the Shares shall be determined as of the time the Option with respect to such Shares is granted. 
 11. Nontransferability Options and Share Purchase Rights. Options and Share Purchase Rights granted under the Plan may not be sold,
pledged, assigned, hypothecated, gifted, transferred or disposed of in any manner, either voluntarily or involuntarily by operation of law, other than by will or by the laws of descent or distribution, and may be exercised, during the lifetime of
the Optionee, only by such Optionee. 
  

 7 

 12. Share Purchase Rights. 
 (a) Rights to Purchase. Share Purchase Rights may be issued either alone, in addition to, or in tandem with other
awards granted under the Plan and/or cash awards made outside of the Plan. After the Administrator determines that it will offer Share Purchase Rights under the Plan, it shall advise the offeree in writing of the terms, conditions and restrictions
related to the offer, including the number of Shares that such person shall be entitled to purchase, the price to be paid, and the time within which such person must accept such offer. The terms of the offer shall comply in all respects with
Section 260.140.42 of Title 10 of the California Code of Regulations. The offer shall be accepted by execution of a Share Purchase Agreement for Restricted Shares. 
 (b) Repurchase Option. Unless the Administrator determines otherwise, the Share Purchase Agreement for Restricted
Shares set forth in this Section 12 shall grant the Company a repurchase option, subject to the terms of the Companies Act, exercisable upon the voluntary or involuntary termination of the purchaser’s service with the Company for any
reason (including death or Disability). The purchase price for Shares repurchased pursuant to such Share Purchase Agreement shall be the original price paid by the purchaser and may be paid by cancellation of any indebtedness of the purchaser to the
Company. The repurchase option shall lapse at such rate as the Administrator may determine. 
 (c) Other
Provisions. The Share Purchase Agreement for Restricted Shares set forth in this Section 12 shall contain such other terms, provisions and conditions not inconsistent with the Plan as may be determined by the Administrator in its sole
discretion. 
 (d) Rights As Shareholder. Once the Share Purchase Right is exercised, the purchaser shall
have rights equivalent to those of a shareholder (or member) and shall be a shareholder (or member) when its purchase is entered upon the records of the duly authorised transfer agent of the Company. No adjustment shall be made for a dividend or
other right for which the record date is prior to the date the Share Purchase Right is exercised, except as provided in Section 13 of the Plan. 
 13. Adjustments upon Changes in Capitalisation Merger or Asset Sale. 
 (a) Changes in Capitalisation. Subject to any required action by the shareholders (or members) of the Company, the number of shares of Common Shares covered by each outstanding Option or Share
Purchase Right, and the number of shares of Common Shares which have been authorised for issuance under the Plan but as to which no Options or Share Purchase Rights have yet been granted or which have been returned to the Plan upon cancellation or
expiration of an Option or Share Purchase Right, as well as the price per share of Common Shares covered by each such outstanding Option or Share Purchase Right, shall be equitably adjusted for any increase or decrease in the number of issued shares
of Common Shares resulting from a share split, reverse share split, share dividend, spin-off transaction, extraordinary distribution (whether in cash, securities or other property), recapitalization, exchange of shares, combination or
reclassification of the Common Shares, or any other increase or decrease in the number or issued shares of Common Shares effected without receipt of consideration by the Company. The conversion of any convertible securities of the Company shall not
be deemed to have been “effected without receipt of consideration.” Such adjustment shall be made by the Board in such a manner as the Board deems appropriate in order to prevent the dilution or enlargement of benefits under the Options or
Share Purchase Rights. The adjustments determined by the Board shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of any class, or securities convertible into shares of any class, shall
affect, and no adjustment by reason thereof shall be made with respect to the number or price of Common Shares subject to an Option or Share Purchase Right. 
 (b) Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, the
Administrator shall notify each Optionee as soon as practicable prior to the effective date of such proposed transaction. The Administrator in its discretion may provide for an Optionee to have the right to exercise its Option or Share Purchase
Right until fifteen (15) days prior to such transaction as to all of the Optioned Shares covered thereby, including Shares as to which the Option or Share Purchase Right would not otherwise be exercisable. In addition, the Administrator may
provide that any Company repurchase option applicable to any Shares purchased upon exercise of an Option or Share Purchase Right shall lapse as

  

 8 

 
to all such Shares, provided the proposed dissolution or liquidation takes place at the time and in the manner contemplated. To the extent it has not been previously exercised, an Option or Share
Purchase right will terminate immediately prior to the consummation of such proposed action. 
 (c) Merger or
Asset Sale. In the event of a merger of the Company with or into another corporation, or the sale of all or substantially all of the assets of the Company, each outstanding Option and Share Purchase Right shall be assumed or an equivalent option
or right substituted by the successor corporation or a Parent or subsidiary of the successor corporation. In the event that the successor corporation refuses or is unable to assume or substitute for the Option or Share Purchase Right, the Optionee
shall fully vest in, and have the right to exercise, the Option or Share Purchase Right as to all of the Optioned Shares, including Shares as to which it would not otherwise be vested or exercisable. If an Option or Share Purchase Right becomes
fully vested and exercisable in lieu of assumption or substitution in the event of a merger or a sale of assets, the Administrator shall notify the Optionee in writing that the Option or Share Purchase Right shall be fully exercisable for a period
of fifteen (15) days from the date of such notice, and the Option or Share Purchase Right shall terminate upon the expiration of such period. For the purposes of this paragraph, the Option or Share Purchase Right shall be considered assumed if,
following the merger or sale of assets, the option or right confers the right to purchase or receive, for each Share of Optioned Shares subject to the Option or Share Purchase Right immediately prior to the merger or sale of assets, the
consideration (whether shares, cash or other securities or property) received in the merger or sale of assets by holders of Common Shares for each Share held on the effective date of the transaction (and if holders were offered a choice of
consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares); provided, however, that if such consideration received in the merger or sale of assets is not solely common shares of the successor corporation
or its Parent, the Administrator may, with consent of the successor corporation, provide for the consideration to be received upon the exercise of the Option or Share Purchase Right, for each Share of Optioned Shares subject to the Option or Share
Purchase Right, to be solely common shares of the successor corporation or its Parent equal in fair market value to the per share consideration received by holders of Common Shares in the merger or sale of assets. 
 14. Time of Granting Options and Share Purchase Rights. The date of grant of an Option or Share Purchase Right shall, for all
purposes, be the date on which the Administrator makes the determination granting such Option or Share Purchase Right; provided, however, that if the Administrator determines that such grant shall be as of some future date, the date of grant shall
be such future date. Notice of the determination shall be given to each Service Provider to whom an Option or Share Purchase Right is so granted within a reasonable time after the date of such grant. 
 15. Amendment and Termination of the Plan. 
 (a) Amendment and Termination. The Board may amend or terminate the Plan from time to time in such respects as the
Board may deem advisable and shall use its reasonable effort to make amendments which may be required so that Options intended to be Incentive Stock Options shall continue to be Incentive Stock Options for the purpose of the Code, except that,
without approval of the holders of a majority of the Company’s outstanding shares, no such revision or amendment shall: 
 (i) Other than in connection with an adjustment under Section 13 of the Plan, increase the number of Common Shares subject to the Plan; 
 (ii) Materially increase the benefits accruing to participants under the Plan; or 
 (iii) Extend the term of the Plan. 
 (b) Shareholder Approval. The Board shall obtain shareholder (or member) approval of any amendment to the Plan to the
extent necessary and desirable to comply with Applicable Laws. 
 (c) Effect of Amendment or Termination.
Except as otherwise provided in Section 13, any amendment or termination of the Plan shall not affect Options already granted and such Options shall remain in full force and effect as if the Plan had not been amended or terminated, unless
mutually agreed otherwise between the Optionee and the Company, which agreement must be in writing and signed by the Optionee

  

 9 

 
and the Company. Termination of the Plan shall not affect the Administrator’s ability to exercise the powers granted to it hereunder with respect to Options granted under the Plan prior to
such termination. 
 16. Conditions Upon Issuance of Shares. 
 (a) Shares shall not be issued pursuant to the exercise of an Option unless the exercise of such Option and the issuance and
delivery of such Shares pursuant thereto shall comply with Applicable Laws, and shall be further subject to the approval of counsel for the Company with respect to such compliance. 
 (b) As a condition to the exercise of an Option, the Board may require the person exercising such Option to execute an
agreement with, and/or may require the person exercising such Option to make any representation and warranty to, the Company as may in the judgment of counsel to the Company be required under Applicable Laws, including but not limited to a
representation and warranty that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required. 
 17. Reservation of Shares. The Company, during the term of the Plan, at all times shall keep available such number of authorized but
unissued Shares as shall be necessary to satisfy the requirements of the Plan. 
 18. Inability to Obtain Authority. The
Company, during the term of the Plan, shall use diligent efforts to seek to obtain from appropriate regulatory agencies any requisite authorisation in order to issue and sell such number of Shares as shall be sufficient to satisfy the requirements
of the Plan. The inability of the Company to obtain the requisite authorisation(s) deemed necessary by the Company’s counsel for the lawful issuance and sale of any Shares hereunder, or the inability of the Company to confirm to its
satisfaction that any issuance and sale of any Shares hereunder will meet applicable legal requirements, shall relieve the Company of any liability in respect to the failure to issue or sell such Shares. 
 19. Shareholder Approval. Continuance of the Plan shall be subject to approval by the shareholders (or members) of the Company within
twelve (12) months before or after the date the Plan is adopted by the Board. Such shareholder (or member) approval shall be obtained in the degree and manner required under Applicable Laws. 
 20. Liability of Company. The Company, its Parent or any Subsidiary which is in existence or hereafter comes into existence shall not
be liable to an Optionee or other person if it is determined for any reason by the Internal Revenue Service or any court having jurisdiction that any Options intended to be Incentive Stock Options granted hereunder do not qualify as incentive stock
options within the meaning of Section 422 of the Code. 
 21. Information to Optionee. Upon Optionee’s request,
the Company shall provide without charge annually to each Optionee during the period its Option is outstanding copies of a balance sheet and income statement of the Company. In the event that the Company provides annual reports or periodic reports
to its shareholders (or members) during the period in which an Optionee’s Option or Share Purchase Right is outstanding, the Company shall provide to such Optionee a copy of each such report upon Optionee’s request. 
 22. Notices. Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal
delivery or upon deposit in the mail, as first class, registered or certified mail, with postage and fees prepaid and addressed (i) if to the Company, at its principal place of business, attention: Secretary, or (ii) if to the Optionee at
its address as set forth on the signature page of the Option Agreement, or at such other address as either party may from time to time designate in writing to other. It shall be the obligation of each Optionee and each transferee holding Shares
purchased upon exercise of an Option or Share Purchase Right to provide the Secretary of the Company, by letter mailed as provided hereinabove, with written notice of its direct mailing address. 
 23. No Enlargement of Rights As Service Provider. This Plan is purely voluntary on the part of the Company, and the continuance of
the Plan shall not be deemed to constitute a contract between the Company and

  

 10 

 
any Service Provider, or to be consideration for or a condition of the relationship of any Service Provider with the Company. Nothing contained in the Plan shall be deemed to give any Service
Provider the right to be retained in the employ or service of the Company, its Parent, Subsidiary or a successor corporation, or to interfere with the right of the Company or any such corporations to discharge or retire any Service Provider at any
time with or without cause and with or without notice. No Service Provider shall have any right to or interest in Options authorised hereunder prior to the grant thereof to such Service Provider, and upon such grant such Service Provider shall have
only such rights and interests as are expressly provided herein, subject, however, to all applicable provisions of the Company’s Memorandum of Association and Bylaws, as the same may be amended from time to time. 
 24. Legends on Certificates. 
 (a) Unless an appropriate registration statement is filed pursuant to the Securities Act with respect to the Options and Shares issuable under the Plan, each document or certificate representing such
Options or Shares shall be endorsed thereon with a legend substantially as follows: 
 “THIS OPTION AND THE SECURITIES
WHICH MAY BE PURCHASED UPON EXERCISE OF THIS SECURITY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO
SALE, TRANSFER OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATING THERETO OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.” 
 (b) Each document or certificate representing the Options or Shares issuable under the Plan shall also contain legends as may
be required under Applicable Laws including applicable blue sky laws or by any Share Purchase Agreement or other agreement the execution of which is a condition to the exercise of an Option or Share Purchase Right under the Plan. 
 25. Invalid Provisions. In the event that any provision of the Plan is found to be invalid or otherwise unenforceable under
Applicable Laws, such invalidity or unenforceability shall not be construed as rendering any other provisions contained herein as invalid or unenforceable, and all such other provisions shall be given full force and effect to the same extent as
though the invalid or unenforceable provision were not contained herein. 
  

 11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}]]